GlassScriptPhysician profile
Julia L King
NPI 1659548253
$99,357.28
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $27K · 2022: $38K · 2023: $22K · 2024: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Consulting Fee: $6,130 · Travel and Lodging: $5,165 · Food and Beverage: $2,685 · Honoraria: $1,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,065.00 |
| Consulting Fee | $6,130.00 |
| Travel and Lodging | $5,164.77 |
| Food and Beverage | $2,685.00 |
| Honoraria | $1,164.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $63,099.42 | 2021-2024 | Tavalisse, Rezlidhia |
| Incyte Corporation | $20,580.66 | 2021-2024 | Jakafi, Monjuvi |
| Beigene USA, INC. | $11,744.94 | 2022-2024 | Brukinsa |
| Abbvie INC. | $2,829.59 | 2022 | |
| Pharmaessentia USA Corporation | $513.00 | 2024 | Besremi |
| Genentech USA, INC. | $148.17 | 2023 | Columvi, Polivy |
| Emd Serono, INC. | $121.71 | 2024 | |
| Amgen INC. | $121.22 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $79.99 | 2022 | |
| Sanofi-Aventis U.S. LLC | $78.99 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $20.52 | 2022 | |
| Idorsia Pharmaceuticals US INC | $19.07 | 2024 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.